Larynx Clinical Trial
Official title:
Window of Opportunity Trial of Nivolumab and Tadalafil in Patients With Squamous Cell Carcinoma of the Head and Neck
This randomized pilot early phase I trial studies how well nivolumab with or without tadalafil work in treating patients with head and neck squamous cell carcinoma that has come back and can be removed by surgery. Monoclonal antibodies, such as nivolumab, may interfere with the ability of tumor cells to grow and spread. Tadalafil may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving nivolumab and tadalafil may work better in treating patients head and neck squamous cell carcinoma.
PRIMARY OBJECTIVES: I. To investigate whether adding the PDE5 inhibitor, tadalafil, to nivolumab therapy affects intratumoral and systemic anti-tumor immunity. SECONDARY OBJECTIVES: I. Characterize the combined effects of nivolumab and tadalafil on safety, exosome composition and function, the composition of intratumoral immune cell populations, wound healing, and tumor radiographic response. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05746780 -
Bilateral Elective Neck Dissection in Salvage Total Laryngectomy
|
||
| Active, not recruiting |
NCT03529422 -
Durvalumab With Radiotherapy for Adjuvant Treatment of Intermediate Risk SCCHN
|
Phase 2 | |
| Completed |
NCT02126969 -
A Study of Chemo +/- Low-dose Radiation as Induction Therapy in SCCHN
|
Phase 2 | |
| Completed |
NCT01263873 -
Examining the Ease of Intubation Using the Parker Flex-Tip® or a Standard Endotracheal Tube
|
N/A | |
| Completed |
NCT03162731 -
Nivolumab, Ipilimumab, and Radiation Therapy in Treating Patients With Stage III-IVB Head and Neck Cancer
|
Early Phase 1 | |
| Enrolling by invitation |
NCT03269396 -
Laryngeal Allograft Transplantation
|
N/A | |
| Completed |
NCT01649973 -
Study for Appropriate Operating Table Height for Endotracheal Intubation Under Direct Laryngoscopy
|
N/A | |
| Withdrawn |
NCT04168671 -
CLE During Exercise Testing in Asthma
|
N/A | |
| Completed |
NCT01321892 -
Ex Vivo Multimodal Imaging of Upper Aerodigestive Epithelium
|
N/A | |
| Recruiting |
NCT05636410 -
Ultrasound Assessment of the Larynx and Trachea in the Neonatal Period
|
||
| Recruiting |
NCT05565430 -
Vocal Cord Responses During Hyperventilation in Normal Individuals and in Mild and Severe Asthmatics.
|
||
| Completed |
NCT03109873 -
Metformin Hydrochloride in Affecting Cytokines and Exosomes in Patients With Head and Neck Cancer
|
Early Phase 1 | |
| Active, not recruiting |
NCT03737968 -
Window of Opportunity Trial of Durvalumab (MEDI4736) or Durvalumab/Tremelimumab as Neoadjuvant Chemotherapy to Identify Immune Dynamics in Surgically Resectable Head and Neck Cancer Patients.
|
Phase 2 | |
| Recruiting |
NCT03109171 -
Accuracy of the Sensory Test Using the Laryngopharyngeal Endoscopic Esthesiometer in Obstructive Sleep Apnea
|
N/A | |
| Completed |
NCT02761239 -
Innervation of Human Cricopharyngeal Muscle By Recurrent Laryngeal and External Branch of Superior Laryngeal Nerve
|
N/A | |
| Recruiting |
NCT05145556 -
Teach Intubation by Novices in Anaesthesiology
|
N/A | |
| Completed |
NCT03030781 -
Relationship of Cricoid With the Right and Left Bronchial Diameters in the Pediatric Population Using Three-dimensional Imaging.
|
N/A | |
| Withdrawn |
NCT02065128 -
The Efficacy of Capsaicin Sensitivity Testing in Patients With Irritable Larynx Syndrome
|
N/A | |
| Active, not recruiting |
NCT03854032 -
Nivolumab and BMS986205 in Treating Patients With Stage II-IV Squamous Cell Cancer of the Head and Neck
|
Phase 2 | |
| Active, not recruiting |
NCT03076281 -
Metformin Hydrochloride and Doxycycline in Treating Patients With Head and Neck Squamous Cell Carcinoma That Can Be Removed by Surgery
|
Phase 2 |